AIA
GMAB icon

Avalon Investment & Advisory’s Genmab GMAB Stock Holding History

Avalon Investment & Advisory’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-23,963
Closed -$974K – 354
2020
Q4 		$974K Buy
23,963
+1,116
+5% +$41.7K 0.02% 249
2020
Q3 		$836K Buy
+22,847
New +$826K 0.02% 228

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Avalon Investment & Advisory's GMAB Position: Q1 2021 in Review

Avalon Investment & Advisory sold out of Genmab (GMAB) in Q1 2021, closing a stake of 23,963 shares — an estimated $974K sold.

Avalon Investment & Advisory first reported a position in GMAB in Q3 2020 and held it in 2 quarters. The position peaked at $974K in Q4 2020. 209 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.

  • Avalon Investment & Advisory reported no remaining Genmab position as of Q1 2021 after selling out during the quarter.
  • Avalon Investment & Advisory sold 23,963 Genmab shares in Q1 2021, an estimated $974K.
  • Avalon Investment & Advisory first reported a position in Genmab in Q3 2020 and held it in 2 quarters.
  • Avalon Investment & Advisory's Genmab position peaked at $974K in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Genmab as of Q1 2021.

Based on Avalon Investment & Advisory's 13F filing for Q1 2021, filed 13 May 2021.